Ara
Toplam kayıt 28, listelenen: 21-28
Adjusting the QRS duration by body mass index for prediction of response to cardiac resynchronization therapy: Does one QRS size fit all?
(Wiley, 2016)
Background: QRS duration (QRSd) is known to be affected by body weight and length. We tested the hypothesis that adjusting the QRSd by body mass index (BMI) may provide individualization for patient selection and improve ...
Assessment of energy expenditure, physical activity and sleep pattern in patients with frequent symptomatic ventricular ectopic beats
(Masson Editeur, 2016)
Background. Ventricular ectopic beats (VEBs) are considered as benign ventricular arrhythmias in patients without structural heart disease. However, symptomatic frequent VEBs can adversely affect energy metabolism. The ...
Native electrocardiographic qrs duration after cardiac resynchronization therapy: The impact on clinical outcomes and prognosis
(Churchill Livingstone Inc Medical Publishers, 2016)
Background: We investigated whether reversed electrical remodeling (RER), defined as narrowing of the native electrocardiographic QRS duration after cardiac resynchronization therapy (CRT), might predict prognosis and ...
Effect of cardiac resynchronization therapy on mitral valve geometry: A novel aspect as "reversed mitral remodeling"
(Springer, 2018)
Amelioration of the valvular geometry is a possible mechanism for mitral regurgitation (MR) improvement in patients receiving cardiac resynchronization therapy (CRT). We aimed to establish the precise definition, incidence, ...
Long-term outcomes of absorb bioresorbable vascular scaffold using predilation, sizing, and postdilation protocol in a real-world patient population
(NLM (Medline), 2021)
OBJECTIVE: Bioresorbable vascular scaffolds (BVSs) have been a disappointment in the evolution of drug-eluting stents used in percutaneous coronary intervention because an excessive number of thrombotic complications have ...
Long-term results of long segment coronary artery lesions overlapped with novolimus-eluting DESolve scaffold: Disappointment or futuristic?
(Turkish Society of Cardiology, 2021)
Objective: The data on using novolimus-eluting DESolve bioresorbable scaffolds (BVS) for long-segment coronary artery lesions remains insufficient. In this study, our main objective was to assess the long-term effects of ...
How accurate are manufacturers' recommendations in determining ineligibility for transfemoral transcatheter aortic valve implantation?
(Sociedade Portuguesa De Cardiologia, 2023)
Introduction: Up to one-third of patients indicated for transcatheter aortic valve implantation (TAVI) may be unsuitable for transfemoral TAVI (TF-TAVI) according to manufacturers' recommendations and numerous professional ...
Long-term outcomes of patients presenting with acute coronary syndrome and implanted with bioresorbable scaffold
(Yuzuncu Yıl University Faculty of Medicine, 2022)
A bioresorbable scaffold (BRS) has been used in the latest stages of stent technology and is a less-known material than drug-eluting stents (DES). In this study, we aimed to evaluate the long-term clinical outcomes of BRS ...